Select Bibliography

 Search for any words:
Excel csv Word PDF RIS
  Filter by any of these (after searching):
2008
Year
      
PubType
      
Endpoint
      
Analysis
      
Datasharing
      
Committee
      
Program
      
Meeting
      
Funding
                            

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 144 items

Low-dose interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720 Google Scholar
,  ,  ... -  ASCO   -  J Clin Oncol   -  2008    
Abstract -  Secondary -  Primary -  Leukemia -  CALGB-10201 ,  CALGB-10502 ,  CALGB-10503 ,  CALGB-10603 ,  CALGB-19808 ,  CALGB-8525 ,  CALGB-8923 ,  CALGB-9022 ,  CALGB-9222 ,  CALGB-9420 ,  CALGB-9621 ,  CALGB-9720
High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study    QxMD    Google Scholar
,  ,  ... -    -  Blood   -  2008    
Manuscript -  Secondary -  Primary -  Leuk Corr Sci -  CALGB-19808 ,  CALGB-20502 ,  CALGB-8461 ,  CALGB-9621 ,  CALGB-9665


Copyright ©2013 - 2023 Alliance Foundation. All rights reserved.